|
1
|
Pedroza-Torres A, Campos-Parra AD,
Millan-Catalan O, Loissell-Baltazar YA, Zamudio-Meza H, de León
Cantú D, Montalvo-Esquivel G, Isla-Ortiz D, Herrera LA,
Ángeles-Zaragoza Ó, et al: MicroRNA-125 modulates radioresistance
through targeting p21 in cervical cancer. Oncol Rep. 39:1532–1540.
2018.PubMed/NCBI
|
|
2
|
Ho CM, Chien TY, Huang SH, Wu CJ, Shih BY
and Chang SC: Multivariate analysis of the prognostic factors and
outcomes in early cervical cancer patients undergoing radical
hysterectomy. Gynecol Oncol. 93:458–464. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hildesheim A, Gonzalez P, Kreimer AR,
Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M,
Sidawy M, Schiller JT, et al: Costa Rica HPV Vaccine Trial (CVT)
Group: Impact of human papillomavirus (HPV) 16 and 18 vaccination
on prevalent infections and rates of cervical lesions after
excisional treatment. Am J Obstet Gynecol. 215:212.e1–212.e15.
2016. View Article : Google Scholar
|
|
4
|
Gill SS, Jana AM, Shrivastav A, Sharma S
and Sharma A: The carcinogenic potential of E6& E7 genes of
high-risk HPV compared with E6, E7 genes of low-risk HPV in human
cervical cancer: A review. Int J Pharm Sci Res. 5:703–712.
2014.
|
|
5
|
Karanikas V, Zamanakou M, Kerenidi T,
Dahabreh J, Hevas A, Nakou M, Gourgoulianis KI and Germenis AE:
Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer. Cancer
Biol Ther. 6:1258–1262. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bagarazzi ML, Yan J, Morrow MP, Shen X,
Parker RL, Lee JC, Giffear M, Pankhong P, Khan AS, Broderick KE, et
al: Immunotherapy against HPV16/18 generates potent TH1 and
cytotoxic cellular immune responses. Sci Transl Med.
4:155ra1382012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Amador-Molina A, Hernández-Valencia JF,
Lamoyi E, Contreras-Paredes A and Lizano M: Role of innate immunity
against human papillomavirus (HPV) infections and effect of
adjuvants in promoting specific immune response. Viruses.
5:2624–2642. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vidal JP, Felix SP, Chaves CB, Patury P,
Franco VF, de Morais EA, de Carvalho NA, Carvalho AC, Neto Almeida
OF, Vieira LM, et al: Genetic diversity of HPV16 and HPV18 in
Brazilian patients with invasive cervical cancer. J Med Virol.
88:1279–1287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reuschenbach M, Waterboer T, Einenkel J,
Wallin K-L, Dillner J, Heilig B, Hamsikova E, Pawlita M, von Knebel
Doeberitz M and Wentzensen N: Characterization of humoral immune
responses against p16 in HPV-associated and non HPV-associated
disease. Cancer Res. 68 Suppl 9:21262008.
|
|
10
|
Cilfone NA, Ford CB, Marino S, Mattila JT,
Gideon HP, Flynn JL, Kirschner DE and Linderman JJ: Computational
modeling predicts IL-10 control of lesion sterilization by
balancing early host immunity-mediated antimicrobial responses with
caseation during mycobacterium tuberculosis infection. J Immunol.
194:664–677. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ekalaksananan T, Malat P, Pientong C,
Kongyingyoes B, Chumworathayi B and Kleebkaow P: Local cervical
immunity in women with low-grade squamous intraepithelial lesions
and immune responses after abrasion. Asian Pac J Cancer Prev.
15:4197–4201. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bergner S, Halec G, Schmitt M, Aubin F,
Alonso A and Auvinen E: Individual and complementary effects of
human papillomavirus oncogenes on epithelial cell proliferation and
differentiation. Cells Tissues Organs. 201:97–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Palacios F, Moreno P, Morande P, Abreu C,
Correa A, Porro V, Landoni AI, Gabus R, Giordano M, Dighiero G, et
al: High expression of AID and active class switch recombination
might account for a more aggressive disease in unmutated CLL
patients: Link with an activated microenvironment in CLL disease.
Blood. 115:4488–4496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang M, Liu Y, Liu S, Zhang B, Si J, Xu
X, Chen L and Song G: Assay and L1 gene sequence analysis of human
papillomavirus type 6 and 11 in condylomata acuminata. Zhongguo Yi
Xue Ke Xue Yuan Xue Bao. 22:463–466. 2000.(In Chinese). PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Landoni F, Colombo A, Milani R, Placa F,
Zanagnolo V and Mangioni C: Randomized study between radical
surgery and radiotherapy for the treatment of stage IB-IIA cervical
cancer: 20-year update. J Gynecol Oncol. 28:e342017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Leto M, Santos Júnior GF, Porro AM and
Tomimori J: Human papillomavirus infection: Etiopathogenesis,
molecular biology and clinical manifestations. An Bras Dermatol.
86:306–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiménez-Wences H, Martínez-Carrillo DN,
Peralta-Zaragoza O, Campos-Viguri GE, Hernández-Sotelo D,
Jiménez-López MA, Muñoz-Camacho JG, Garzón-Barrientos VH,
Illades-Aguiar B and Fernández-Tilapa G: Methylation and expression
of miRNAs in precancerous lesions and cervical cancer with HPV16
infection. Oncol Rep. 35:2297–2305. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wagner M, Bennetts L, Patel H, Welner S,
de Sanjose S and Weiss TW: Global availability of data on HPV
genotype-distribution in cervical, vulvar and vaginal disease and
genotype-specific prevalence and incidence of HPV infection in
females. Infect Agent Cancer. 10:132015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Araujo-Neto AP, Ferreira-Fernandes H,
Amaral CMM, Santos LG, Freitas AC, Silva-Neto JC, Rey JA, Burbano
RR, Silva BB, Yoshioka FKN, et al: Lack of detection of human
papillomavirus DNA in prostate carcinomas in patients from
northeastern Brazil. Genet Mol Biol. 39:24–29. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vuitton DA, Azizi A, Richou C, Vuitton L,
Blagosklonov O, Delabrousse E, Mantion GA and Bresson-Hadni S:
Current interventional strategy for the treatment of hepatic
alveolar echinococcosis. Expert Rev Anti Infect Ther. 14:1179–1194.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chung EY, Liu J, Zhang Y and Ma X:
Differential expression in lupus-associated IL-10 promoter
single-nucleotide polymorphisms is mediated by poly(ADP-ribose)
polymerase-1. Genes Immun. 8:577–589. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Naing A, Papadopoulos KP, Autio KA, Ott
PA, Patel MR, Wong DJ, Falchook G, Pant S, Whiteside M, Rasco D, et
al: Anti-tumor activity of PEGylated human IL-10 (AM0010) in renal
cancer alone and in combination with anti-PD1. Ann Oncol.
27:364PD2016. View Article : Google Scholar
|
|
24
|
Barbisan G, Pérez LO, Contreras A and
Golijow CD: TNF-α and IL-10 promoter polymorphisms, HPV infection,
and cervical cancer risk. Tumour Biol. 33:1549–1556. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kemmerling R, Weyland D, Kiesslich T,
Illig R, Klieser E, Jäger T, Dietze O and Neureiter D: Robust
linear regression model of Ki-67 for mitotic rate in
gastrointestinal stromal tumors. Oncol Lett. 7:745–749. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Muñoz N, Hernandez-Suarez G, Méndez F,
Molano M, Posso H, Moreno V, Murillo R, Ronderos M, Meijer C and
Muñoz A: Instituto Nacional de Cancerología HPV Study Group:
Persistence of HPV infection and risk of high-grade cervical
intraepithelial neoplasia in a cohort of Colombian women. Br J
Cancer. 100:1184–1190. 2009. View Article : Google Scholar : PubMed/NCBI
|
